Researchers Receive NIH Funds for Adjuvant Research to Boost Coronavirus Vaccines
Researchers have received funding from the National Institute of Allergy and Infectious Diseases, part of the National Institutes of Health, to screen and evaluate certain molecules known as adjuvants that may improve the ability of coronavirus vaccines to stimulate the immune system and generate appropriate responses necessary to protect the general population against the virus.
Adjuvants are used with some vaccines to help them create stronger protective immune responses in persons receiving the vaccine. The research team will screen a library of various adjuvant combinations to quickly identify those that may be most useful to enhance the effects of both protein- and RNA-based coronavirus vaccines under development.
Spotlight
Half of Earth’s satellites restrict use of climate data
Mariel Borowitz
Science Friday —
Project Q Atlanta —
The Atlanta Journal-Constitution —
Georgia Health News —
The Atlanta Journal-Constitution —
Kentez Craig grew up in Atlanta with two parents who served as first responders working as paramedics for local hospitals. Now, as a master's student of engineering, he is inspired by his parents as he helps develop and build protective equipment for healthcare professionals on the front lines fighting the battle against COVID-19.
The slightest bit of shear tension makes gecko adhesion surfaces grip, and the release of that same tension makes them let go. The same gripping surfaces can pick up objects of all shapes, sizes, and materials with the exception of Teflon and other non-stick surfaces. Credit: Georgia Tech / Varenberg lab
A research team at the Georgia Institute of Technology has created a prototype for a low-cost, portable emergency ventilator that uses electronic sensors and computer control to manage key clinical parameters such as respiration rate, tidal volume (the amount of air moved into and out of the lungs during each cycle), inspiration/expiration ratio, and pressure on the lungs.
